These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 31983323)

  • 1. What Is the Best Mix of Population-Wide and High-Risk Targeted Strategies of Primary Stroke and Cardiovascular Disease Prevention?
    Feigin VL; Brainin M; Norrving B; Gorelick PB; Dichgans M; Wang W; Pandian JD; Martins SCO; Owolabi MO; Wood DA; Hankey GJ
    J Am Heart Assoc; 2020 Feb; 9(3):e014494. PubMed ID: 31983323
    [No Abstract]   [Full Text] [Related]  

  • 2. Predicting the impact of population level risk reduction in cardio-vascular disease and stroke on acute hospital admission rates over a 5 year period--a pilot study.
    Whitfield MD; Gillett M; Holmes M; Ogden E
    Public Health; 2006 Dec; 120(12):1140-8. PubMed ID: 17084425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of effective screening strategies for cardiovascular disease prevention in a developing country: using cardiovascular risk-estimation and risk-reduction tools for policy recommendations.
    Selvarajah S; Haniff J; Kaur G; Guat Hiong T; Bujang A; Chee Cheong K; Bots ML
    BMC Cardiovasc Disord; 2013 Feb; 13():10. PubMed ID: 23442728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cases in Precision Medicine: A Personalized Approach to Stroke and Cardiovascular Risk Assessment in Women.
    Bello NA; Miller EC; Cleary KL; Wapner R
    Ann Intern Med; 2019 Dec; 171(11):837-842. PubMed ID: 31610550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of cardiovascular disease and stroke: meeting the challenge.
    Tomaselli GF
    JAMA; 2011 Nov; 306(19):2147-8. PubMed ID: 22089723
    [No Abstract]   [Full Text] [Related]  

  • 6. [Primary prevention of cardiovascular disease should be based on absolute risk assessment].
    Nilsson PM
    Lakartidningen; 2005 Feb 14-20; 102(7):496-7. PubMed ID: 15768700
    [No Abstract]   [Full Text] [Related]  

  • 7. The role of legislators in the prevention of heart disease and stroke.
    Murry T; Carney B; White A
    N C Med J; 2012; 73(6):466-8. PubMed ID: 23617161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The hypertension initiative of South Carolina. Promoting cardiovascular health through better blood pressure control.
    Giese M; Lackland DT; Egan BM
    J S C Med Assoc; 2001 Feb; 97(2):57-62. PubMed ID: 11235117
    [No Abstract]   [Full Text] [Related]  

  • 9. A systematic review on the application of cardiovascular risk prediction models in pharmacoeconomics, with a focus on primary prevention.
    Stevanovic J; Postma MJ; Pechlivanoglou P
    Eur J Prev Cardiol; 2012 Aug; 19(2 Suppl):42-53. PubMed ID: 22988567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health and Economic Implications of National Treatment Coverage for Cardiovascular Disease in India: Cost-Effectiveness Analysis.
    Basu S; Bendavid E; Sood N
    Circ Cardiovasc Qual Outcomes; 2015 Nov; 8(6):541-51. PubMed ID: 26555122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk stratification could reduce costs in primary prevention of cardiovascular disease.
    Dalton AR; Bull RJ
    BMJ; 2011 Aug; 343():d4913. PubMed ID: 21831937
    [No Abstract]   [Full Text] [Related]  

  • 12. Prevention and care of stroke in low- and middle-income countries; the need for a public health perspective.
    Mendis S
    Int J Stroke; 2010 Apr; 5(2):86-91. PubMed ID: 20446942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A health economic evaluation of aspirin in the primary prevention of cardiovascular disease in Japan.
    Tsutani K; Igarashi A; Fujikawa K; Evers T; Kubin M; Lamotte M; Annemans L
    Intern Med; 2007; 46(4):157-62. PubMed ID: 17301509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resource implications and health benefits of primary prevention strategies for cardiovascular disease in people aged 30 to 74: mathematical modelling study.
    Marshall T; Rouse A
    BMJ; 2002 Jul; 325(7357):197. PubMed ID: 12142309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends and disparities in coronary heart disease, stroke, and other cardiovascular diseases in the United States: findings of the national conference on cardiovascular disease prevention.
    Cooper R; Cutler J; Desvigne-Nickens P; Fortmann SP; Friedman L; Havlik R; Hogelin G; Marler J; McGovern P; Morosco G; Mosca L; Pearson T; Stamler J; Stryer D; Thom T
    Circulation; 2000 Dec; 102(25):3137-47. PubMed ID: 11120707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Status and costs of primary prevention for ischemic stroke in China.
    Zhao JJ; He GQ; Gong SY; He L
    J Clin Neurosci; 2013 Oct; 20(10):1427-32. PubMed ID: 23938016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential and limitations of health policy to improve coronary heart disease prevention and to reduce the burden of disease: A Russian experience.
    Pogosova N; Oganov R; Saner H; Suvorov S; Sokolova O
    Eur J Prev Cardiol; 2018 Nov; 25(16):1725-1734. PubMed ID: 29635927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The New 2019 AHA/ACC Guideline on the Primary Prevention of Cardiovascular Disease.
    Bittner V
    Circulation; 2020 Dec; 142(25):2402-2404. PubMed ID: 30879338
    [No Abstract]   [Full Text] [Related]  

  • 19. Heart disease and stroke statistics--2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee.
    Thom T; Haase N; Rosamond W; Howard VJ; Rumsfeld J; Manolio T; Zheng ZJ; Flegal K; O'Donnell C; Kittner S; Lloyd-Jones D; Goff DC; Hong Y; Adams R; Friday G; Furie K; Gorelick P; Kissela B; Marler J; Meigs J; Roger V; Sidney S; Sorlie P; Steinberger J; Wasserthiel-Smoller S; Wilson M; Wolf P;
    Circulation; 2006 Feb; 113(6):e85-151. PubMed ID: 16407573
    [No Abstract]   [Full Text] [Related]  

  • 20. [Current status and prospects of the prevention and control of cardiovascular diseases].
    Gu DF
    Zhonghua Yu Fang Yi Xue Za Zhi; 2003 Mar; 37(2):75-6. PubMed ID: 15376371
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.